Literature DB >> 7882801

Colorectal manifestations of endocrine disease.

S Sharma1, W E Longo, B Baniadam, A M Vernava.   

Abstract

PURPOSE: The aim of this review is to alert the colon and rectal surgeon to the colorectal manifestations of endocrine disease.
METHODS: This report was obtained by a review of the medical literature. Endocrine disease may initially present as a symptom felt to be referable to colorectal disease. Furthermore symptoms of well-established endocrine disorders may have refractory colorectal symptoms.
RESULTS: Constipation is the most common gastrointestinal symptom of diabetics; however, in patients with brittle diabetes, diarrhea may be chronic and intermittent. Unexplained diarrhea, despite an exhaustive work-up for an etiology, should alert the clinician to the possibility of a pancreatic endocrine tumor. Thyroid disorders, depending on activity of the gland, may have refractory constipation, diarrhea, or steatorrhea as the only presenting symptoms. Constipation is a common symptom of hypercalcemia, secondary to hyperparathyroidism. Primary hyperparathyroidism has been associated with increased incidence of malignancies, specifically of colonic origin. In patients with acromegaly a threefold to eightfold increased risk of colon carcinoma or adenomatous polyps is seen. Chronic adrenal insufficiency may present initially as diarrhea and malabsorption. The adrenal gland is a frequent site of metastases from colorectal cancer. Pheochromocytomas may be a cause of occult gastrointestinal bleeding or ischemic colitis.
CONCLUSION: Unexplained symptoms referable to the colon and rectum should alert the clinician to the possibility of an underlying endocrine disorder.

Entities:  

Mesh:

Year:  1995        PMID: 7882801     DOI: 10.1007/bf02055611

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

Authors:  Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

2.  A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.

Authors:  Jennifer Christie; Sagar Shroff; Nikrad Shahnavaz; Latoya A Carter; Melanie S Harrison; Karan A Dietz-Lindo; John Hanfelt; Shanthi Srinivasan
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 3.  Digestive manifestations of parathyroid disorders.

Authors:  Bassam Abboud; Ronald Daher; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

4.  Hemangiopericytoma in the setting of acromegaly.

Authors:  W Jeffrey Elias; Isa M Hussaina; James B Chadduck; John A Jane; Edward R Laws; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.